{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:03:43Z","timestamp":1791302623265,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.jhep.2012.07.004","type":"journal-article","created":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T06:34:23Z","timestamp":1341988463000},"page":"1037-1043","source":"Crossref","is-referenced-by-count":55,"title":["Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9"],"prefix":"10.1016","volume":"57","author":[{"given":"Kojiro","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Miyagawa-Hayashino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Iwaisako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojiro","family":"Taura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Uemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2012.07.004_b0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.suronc.2007.04.010","article-title":"Liver resection for colorectal liver metastasis","volume":"16","author":"Lochan","year":"2007","journal-title":"Surg Oncol"},{"key":"10.1016\/j.jhep.2012.07.004_b0010","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.sla.0000141198.92114.f6","article-title":"Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival","volume":"240","author":"Adam","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2012.07.004_b0015","doi-asserted-by":"crossref","first-page":"8490","DOI":"10.1200\/JCO.2004.00.6155","article-title":"Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?","volume":"23","author":"Khatri","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2012.07.004_b0020","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","article-title":"The syndrome of hepatic veno-occlusive disease after marrow transplantation","volume":"85","author":"Bearman","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2012.07.004_b0025","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood.V79.10.2784.2784","article-title":"Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan\/cyclophosphamide","volume":"79","author":"Essell","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2012.07.004_b0030","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhep.2012.07.004_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000193603.26265.c3","article-title":"Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases","volume":"243","author":"Karoui","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2012.07.004_b0040","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","article-title":"Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy","volume":"247","author":"Nakano","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2012.07.004_b0045","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood.V89.5.1501","article-title":"Treatment of hepatic veno-occlusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients","volume":"89","author":"Bearman","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2012.07.004_b0050","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1182\/blood-2008-04-149682","article-title":"Angiogenesis alteration by defibrotide: implications for its mechanism of action in severe hepatic veno-occlusive disease","volume":"112","author":"Benimetskaya","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2012.07.004_b0055","first-page":"297","article-title":"Prevention of hepatic veno-occlusive disease by a combination of heparin and prostaglandin E1 in children undergoing hematopoietic stem cell transplantation","volume":"45","author":"Inukai","year":"2004","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.jhep.2012.07.004_b0060","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/sj.bmt.1703061","article-title":"Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation","volume":"27","author":"Iguchi","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jhep.2012.07.004_b0065","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/cncr.23099","article-title":"Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases","volume":"110","author":"Ribero","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jhep.2012.07.004_b0070","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejso.2008.12.013","article-title":"Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX\/FOLFOX therapy of colorectal cancer liver metastases","volume":"35","author":"Klinger","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jhep.2012.07.004_b0075","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2559.2010.03511.x","article-title":"Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis","volume":"56","author":"Rubbia-Brandt","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.jhep.2012.07.004_b0080","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.22758","article-title":"Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats","volume":"49","author":"Mejias","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.07.004_b0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2010.02.027","article-title":"New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis","volume":"53","author":"Wang","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.07.004_b0090","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1161\/01.CIR.97.21.2169","article-title":"Endothelin A receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertension","volume":"97","author":"Pri\u00e9","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2012.07.004_b0095","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.510290615","article-title":"Characterization of a reproducible rat model of hepatic veno-occlusive disease","volume":"29","author":"DeLeve","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.07.004_b0100","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/SLA.0b013e3181a38ed5","article-title":"A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction","volume":"249","author":"Narita","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2012.07.004_b0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/lt.22189","article-title":"Olprinone attenuates excessive shear stress through up-regulation of endothelial nitric oxide synthase in a rat excessive hepatectomy model","volume":"17","author":"Yamanaka","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2012.07.004_b0110","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jnr.22594","article-title":"Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis","volume":"89","author":"Miyazaki","year":"2011","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jhep.2012.07.004_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/taap.1995.1001","article-title":"The relationship between the concentration of the pyrrolizidine alkaloid monocrotaline and the pattern of metabolites released from the isolated liver","volume":"130","author":"Yan","year":"1995","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2012.07.004_b0120","first-page":"135","article-title":"[14C]-Monocrotaline kinetics and metabolism in the rat","volume":"19","author":"Estep","year":"1991","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2012.07.004_b0125","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cardiores.2005.09.019","article-title":"Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells","volume":"69","author":"Wu","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jhep.2012.07.004_b0130","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.onc.1207034","article-title":"Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2\/p38","volume":"23","author":"Lamalice","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2012.07.004_b0135","doi-asserted-by":"crossref","first-page":"13484","DOI":"10.1073\/pnas.0504420102","article-title":"Cdc42GAP regulates c-Jun N-terminal kinase (JNK)-mediated apoptosis and cell number during mammalian perinatal growth","volume":"102","author":"Wang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2012.07.004_b0140","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1083\/jcb.200212114","article-title":"Differential regulation of cell motility and invasion by FAK","volume":"160","author":"Hsia","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jhep.2012.07.004_b0225","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s10637-011-9727-0","article-title":"Synergistic effects of the combination of \u03b2-ionone and sorafenib on metastasis of human hepatoma SK-Hep-1 cells","volume":"30","author":"Huang","year":"2012","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.jhep.2012.07.004_b0230","first-page":"900","article-title":"Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells","volume":"58","author":"Shibata","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2012.07.004_b0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.semcancer.2010.10.011","article-title":"Mitogen-activated protein kinases in hepatocellular carcinoma development","volume":"21","author":"Min","year":"2011","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jhep.2012.07.004_b0160","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/jor.1100180608","article-title":"Biomechanical regulation of matrix metalloproteinase-9 in cultured chondrocytes","volume":"18","author":"Jin","year":"2000","journal-title":"J Orthop Res"},{"key":"10.1016\/j.jhep.2012.07.004_b0165","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1093\/nar\/21.15.3365","article-title":"Cytoskeletal reorganization and TPA differently modify AP-1 to induce the urokinase-type plasminogen activator gene in LLC-PK1 cells","volume":"21","author":"Lee","year":"1993","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2012.07.004_b0170","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1128\/MCB.16.11.5947","article-title":"The Ras-JNK pathway is involved in shear-induced gene expression","volume":"16","author":"Li","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2012.07.004_b0175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1091\/mbc.9.3.561","article-title":"The Ras\/Rac1\/Cdc42\/SEK\/JNK\/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes","volume":"9","author":"Auer","year":"1998","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.jhep.2012.07.004_b0180","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0016-5085(03)01056-4","article-title":"Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition","volume":"125","author":"Deleve","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.07.004_b0185","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/mol.109.056523","article-title":"Sorafenib and vorinostat kill colon cancer cells by CD95-dependent and -independent mechanisms","volume":"76","author":"Walker","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jhep.2012.07.004_b0190","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1517\/17425255.2010.506873","article-title":"Metabolism considerations for kinase inhibitors in cancer treatment","volume":"6","author":"Duckett","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jhep.2012.07.004_b0195","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.canlet.2004.11.039","article-title":"Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo","volume":"226","author":"Wang","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jhep.2012.07.004_b0200","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2012.07.004_b0205","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1245\/s10434-010-1317-4","article-title":"Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy","volume":"18","author":"Tamandl","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jhep.2012.07.004_b0210","doi-asserted-by":"crossref","first-page":"G1045","DOI":"10.1152\/ajpgi.00526.2002","article-title":"Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome","volume":"284","author":"DeLeve","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2012.07.004_b0215","first-page":"S18","article-title":"Does bevacizumab have a protective effect on hepatotoxicity induced by chemotherapy?","volume":"147","author":"Zalinski","year":"2010","journal-title":"J Chir"},{"key":"10.1016\/j.jhep.2012.07.004_b0220","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00417-008-0936-y","article-title":"Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization?","volume":"247","author":"Lu","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812005314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812005314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T16:53:14Z","timestamp":1642697594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827812005314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0168827812005314"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2012.07.004","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}